Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Post by Magnum2on Apr 30, 2020 10:27pm
310 Views
Post# 30974471

What I can say

What I can say Is this story is very new to me...with that said, I have torn this thing apart backwards and forwards...

Their core business, soft tissues, the earnings are increasing in a growing sector.

The Co. has just placed a $6 Million "at will credit facility" into place, so there are no immediate issues with funding shortages.  The credit facility from what I have read seems very friendly and flexible in a time where such a financing could easily have buried the upside on this company, someone inside the LBL needs a huge pat on the back when and if the science moves this beyond their existing products.

The share structure isn't tight, but it isn't beyond control either...the past month had some very large volumes which appears to be slowly moving the base cost higher and into new hands with vision and progress in the works.

While very limited my contact with company has been as others have described, so far true, there fortunately have been no leaks, but the tone is very professional and confident to go thru the entire process to benefit all shareholders equally, all one can ask for IMO.

3 Million options, originally at 7.5 cts, and then pushed to 9 cents...once again fair to the shareholders, more inline with the rules of options, and also showing confidence in increasing the price.

Many similar stem cell trial outcomes/links have been posted over the past several days, with pretty much everyone benefitting/aiding recovery of COVID participants/patients...so far other than previous antiviral medications nothing that I'm aware of has made much progress on the virus....LBL, as small as it is on paper as of this moment walks shoulder to shoulder with other trials in the stem cell process...anyhow time will tell.

Meanwhile the shares/mkt cap of LBL is a fraction of others that have put forth their early stage benefits/results for patients.

While I can not say what is the correct exposure for each person here, I will say based on my comments above, today I have chosen to greatly increase my position in LBL.  Please trade wisely, do your DD.

Cheers,Magnum

<< Previous
Bullboard Posts
Next >>